{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1010000781821904896.json","@type":"Article","resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"ja","@value":"Enhanced systemic T-cell activation following in situ gene therapy with radiotherapy in prostate cancer patients."}],"publication":{"prism:publicationName":[{"@language":"ja","@value":"Int J Radiat Oncol Biol Phys 59"}],"prism:publicationDate":"2004","prism:startingPage":"562","prism:endingPage":"571"},"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000781821904896","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"15790861"},{"@type":"JGN","@value":"JP15790861"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15790861/"}],"notation":[{"@language":"ja","@value":"転移性前立腺癌に対する、IL‐12およびB7‐1遺伝子発現抗腫瘍ワクチンの検討"}]}],"dataSourceIdentifier":[{"@type":"KAKEN","@value":"PRODUCT-10035740"}]}